Premacio, Reynaldo .

HRN: 26-76-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2025
CEFUROXIME 750MG (VIAL)
03/04/2025
03/11/2025
IV
750
Q8
T/c Nephrolitgiasis
Rejected 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines